PrsA mediates AtlA secretion contributing to extracellular DNA release and biofilm formation in the pathogenesis of infective endocarditis.

The role of secretion chaperone-regulated virulence proteins in the pathogenesis of infective endocarditis (IE) induced by viridans streptococci such as is unclear. In this study, we investigated the contribution of the foldase protein PrsA, a putative parvulin-type peptidyl-prolyl isomerase, to the pathogenesis of -induced IE. We found that a -deficient strain had reduced virulence in terms of formation of vegetation on damaged heart valves, as well as reduced autolysis activity, eDNA release and biofilm formation capacity.

ATP13A2 variability in Taiwanese Parkinson's disease.

Mutations in ATP13A2 have been reported to associate with Parkinson's disease (PD). This study investigates the contribution of genetic variants in ATP13A2 to Taiwanese PD. ATP13A2 cDNA fragments from 65 early onset PD (onset <50 years) were sequenced.

[Dynamic observation on splenocyte subsets in mice immunized with recombinant Bb-Eg95-EgA31 vaccine of Echinococcus granulosus].

Objective: To dynamically observe changes of subsets of splenocytes in mice immunized with recombinant Bifidobacteria bifidum (Bb)-Eg95-EgA31 vaccine of Echinococcus granulosus (Eg).

Methods: BALB/c mice were vaccinated by 5 x 10(8) colony forming unit (CFU) orally and 5 x 10(5) CFU intranasally respectively. Mice were killed on week 0, 2, 4, 6, 8, 10, 12, 14, 16, 18 and 20 after immunization respectively, and spleens were separated for cell preparation.

[Construction and expression of recombinant plasmid pET28alpha-Sj26GST of Schistosoma japonicum in Escherichia coli BL21].

Objective: To construct and express recombinant plasmid pET28a-Sj26GST of Schistosoma japonicum (Sj) in Escherichia coli BL21 (DE3).

Methods: The total RNA was extracted from Sj adult worms by ultrasound-breaking. The Sj26GST antigen gene was amplified by RT-PCR from the total RNA, and then cloned into prokaryotic expression plasmid pET28alpha and transformed into E.

[Changes of spleen cytokines in mice immunized with recombinant Bb-Eg95-EgA31 vaccine against Echinococcus granulosus].

Objective: To investigate the level of cytokines in spleen from mice immunized with recombinant Bifidobacteria bifidum(Bb)-Eg95-EgA31 vaccine of Echinococcus granulosus (Eg) and challenged with Eg protoscoleces.

Methods: 56 female BALB/c mice were randomly divided into 7 groups: Recombinant Bb-Eg9S-95-EgA31 vaccine subcutaneous injection (group A), intramuscular injection (B), intranasal immunization (C), oral administration (D), blank vector control (E), Bb control (F) and MRS control (G). Mice in all groups were challenged with 50 Eg protoscoleces on the 8th week after vaccination and sacrificed on the 25th week after infection.

[Research status on DNA vaccine against Cysticercus cellulosae infection].

DNA vaccine against Cysticercus cellulosae infection is a newly emerging vaccine in recent years. It can induce not only humoral immune response, but also a high level cellular immune response. The DNA vaccine displays prominent advantages in the prevention on cysticercosis.

[Inhibition on apoptosis of splenocytes in infected mice by immunization with recombinant Bb-Eg95-EgA31 protein of Echinococcus granulosus].

Objective: To investigate the weight reduction of hydatid cysts and apoptosis of splenocytes in infected mice by recombinant Bifidobacteria bifidum (Bb)-Eg95-EgA31 protein of Echinococcus granulosus (Eg) and challenged with Eg protoscoleces.

Methods: 56 female BALB/c mice were randomly divided into 7 groups. Groups A and B were injected subcutaneously and intramuscularly respectively with 5 x 10(6) colony-forming unit (CFU) recombinant Bb-Eg95-EgA31 protein, group C was immunized intranasally by 5 x 10(5) CFU protein, group D was vaccinated transgastrically by 5 x 10(8) CFU protein, groups E and F were injected subcutaneously with 5 x 10(6) CFU blank vector [Bb (pGEX-1 lambda T)] and Bb respectively, and group G was injected subcutaneously with 100 microl MRS.

[Dynamic observation on immune responses in mice administrated with a recombinant Bb-Eg95-EgA31 vaccine of Echinococcus granulosus].

Aim: To dynamically observe the immune responses in mice administrated with a recombinant Bifidobacteria bifidum (Bb)-Eg95-EgA31 vaccine of Echinococcus granulosus.

Methods: BALB/c mice were immunized orally or intranasally by the vaccine. At indicated times after vaccination, the levels of serum IgG, IgG subclass and IgE were determined by ELISA.

[Research progress in antigens for the diagnosis of alveolar echinococcosis].

Specific antigens of Echinococcus multilocularis is essential for the diagnosis of alveolar echinococcosis and vaccine development. Because of the limited source of nature antigen, its application is restricted. The development of recombinant antigens can provide large amount of antigen under effective quality control.